1st Quarter - Report
OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC. for OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC.
Income
—
Expenses
$330,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 639 - Improving Regulatory Transparency for New Medical Therapies Act, H.R. 9 - Innovation Act (U.S. House of Representatives ONLY)
| Lobbyist | Covered position, as disclosed |
|---|---|
| MOLLY RYAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.